ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1) → 1-[2(S)-Hydroxy-3(S)-(N-(quinoline-2-carbonyl)-(L)-asparaginyl)amino-4-phenyl-butyl]-1-[phenylmethyl]-2-[N-(methoxy-ethoxy-ethoxycarbonyl)-(L)-valyl]-hydrazine

HRID 1291798
ノート
印刷プレビュー

反応式

HRID 1291798 の反応式
CO[CH2:3][CH2:4][O:5][CH2:6][CH2:7][O:8][C:9]([NH:11][C@H:12]([C:16]([OH:18])=O)[CH:13]([CH3:15])[CH3:14])=[O:10].[OH:19][C@H:20]([C@@H:31]([NH:39][C:40](=[O:59])[C@H:41]([CH2:55][C:56](=[O:58])[NH2:57])[NH:42][C:43]([C:45]1[CH:54]=[CH:53][C:52]2[C:47](=[CH:48][CH:49]=[CH:50][CH:51]=2)[N:46]=1)=[O:44])[CH2:32][C:33]1[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=1)[CH2:21][N:22]([CH2:24][C:25]1[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1)[NH2:23].CN([C:63]([O:67]N1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>CN1CCOCC1.CN(C=O)C.C(Cl)Cl>[OH:19][C@H:20]([C@@H:31]([NH:39][C:40](=[O:59])[C@H:41]([CH2:55][C:56](=[O:58])[NH2:57])[NH:42][C:43]([C:45]1[CH:54]=[CH:53][C:52]2[C:47](=[CH:48][CH:49]=[CH:50][CH:51]=2)[N:46]=1)=[O:44])[CH2:32][C:33]1[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=1)[CH2:21][N:22]([CH2:24][C:25]1[CH:26]=[CH:27][CH:28]=[CH:29][CH:30]=1)[NH:23][C:16](=[O:18])[C@H:12]([CH:13]([CH3:14])[CH3:15])[NH:11][C:9]([O:8][CH2:7][CH:6]([O:67][CH3:63])[O:5][CH2:4][CH3:3])=[O:10]
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 3

HCID 2733084Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 54169760N-(2-(2-Methoxyethoxy)-ethoxy)carbonyl-(L)-valineHCID 697828951-[2(S)-Hydroxy-3(S)-(N-(quinoline-2-carbonyl)-(L)-asparaginyl)amino-4-phenylbutyl]-1-[phenylmethyl]-hydrazine

生成物 1

HCID 131720660
1-[2(S)-Hydroxy-3(S)-(N-(quinoline-2-carbonyl)-(L)-asparaginyl)amino-4-phenyl-butyl]-1-[phenylmethyl]-2-[N-(methoxy-ethoxy-ethoxycarbonyl)-(L)-valyl]-hydrazine

試薬・触媒・溶媒 2

HCID 6344Dichloromethane溶媒HCID 19048625Dmf nmm溶媒

実験手順

Analogously to Example 111, 52 mg (0.198 mmol) of N-(2-(2-methoxy-ethoxy)-ethoxy)carbonyl-(L)-valine (Example 82a)) and 100 mg (0.180 mmol) of 1-[2(S)-hydroxy-3(S)-(N-(quinoline-2-carbonyl)-(L)-asparaginyl)amino-4-phenyl-butyl]-1-[phenylmethyl]-hydrazine in 1.8 ml of 0.3M NMM/DMF are reacted with 75.1 mg (0.198 mmol) of HBTU. The evaporation residue is taken up in methylene chloride and washed with 2 portions of 10% citric acid solution, water, saturated NaHCO3 solution and brine. The aqueous phases are extracted a further twice with methylene chloride and the combined organic phases are dried with Na2SO4 and concentrated by evaporation. Column chromatography (SiO2, methylene chloride/methanol 19:1) yields the title compound: TLC Rf (J')=0.08; tRet (V)=13.5 min; FAB-MS (M+H)+ +800.

後処理

  1. washwashed with 2 portions of 10% citric acid solution, water, saturated NaHCO3 solution and brine
  2. extractionThe aqueous phases are extracted a further twice with methylene chloride
  3. dry with materialthe combined organic phases are dried with Na2SO4
  4. concentrationconcentrated by evaporation

出典と根拠

ORDレコード
ord-43fc557bfd2b4c69804073f28e5b88ea
出典データセット
uspto-grants-1998_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US05753652

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート